Inventor
John P. Duffy
Inventor
Northborough, MA, US
Overview
Patents· 36 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes21%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium9%
C07BGeneral methods of organic chemistry8%
C07KPeptides2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,875,855Inhibitors of influenza viruses replication202010,874,673Inhibitors of influenza viruses replication202010,501,439DNA-PK inhibitors201910,442,791DNA-PK inhibitors201910,391,095DNA-PK inhibitors201910,076,521DNA-PK inhibitors201810,039,762Inhibitors of influenza viruses replication20189,925,188'DNA-PK inhibitors and uses thereof'20189,908,878'Inhibitors of influenza viruses replication'20189,878,993'DNA-PK inhibitors for treatment of cancer'20189,808,459'Inhibitors of influenza viruses replication'20179,592,232'DNA-PK inhibitors'20179,518,056'Inhibitors of influenza viruses replication'20169,394,302'Inhibitors of influenza viruses replication'20169,376,448'DNA-PK inhibitors'20169,345,708'Inhibitors of influenza viruses replication'20169,296,701'DNA-PK inhibitors'20169,051,319'Inhibitors of influenza viruses replication'20158,937,064'Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors'20158,871,774'Inhibitors of influenza viruses replication'20148,829,007'Inhibitors of influenza viruses replication'20148,741,912'Deazapurines useful as inhibitors of Janus kinases'20148,633,205'Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases'20148,580,802'Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases'20138,338,412'Inhibitors of P38'20128,163,732'Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase'20127,951,809'Inhibitors of p38'20117,592,340'Quinoxalines useful as inhibitors of protein kinases'20097,365,072'Inhibitors of p38'20087,329,652'Diaminotriazole compounds useful as protein kinase inhibitors'20087,205,305'Inhibitors of p38'20076,608,060'Inhibitors of p38'20036,162,790'Inhibitors of interleukin-1.beta. converting enzyme'20006,147,080'Inhibitors of p38'20005,945,418'Inhibitors of p38'19995,843,904'Inhibitors of interleukin-1.beta.converting enzyme'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2020Patents assigned to VERTEX PHARMA (35)· patent assignee history
1998–2000Based in Brighton, MA, US· patent location history
1999–2003Based in Westborough, MA, US· patent location history
2007–2020Based in Northborough, MA, US· patent location history
2012–2015Patents assigned to DUFFY JOHN (5)· patent assignee history
2012–2015Patents assigned to SALITURO FRANCESCO (5)· patent assignee history
2012–2014Patents assigned to WANG TIANSHENG (4)· patent assignee history
2013–2015Patents assigned to PIERCE ALBERT (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERTEX PHARMA | 35 | 1998–2020 |
| DUFFY JOHNself | 5 | 2012–2015 |
| SALITURO FRANCESCO | 5 | 2012–2015 |
| PIERCE ALBERT | 4 | 2013–2015 |
| WANG TIANSHENG | 4 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Northborough, Massachusetts, US | 31 | 2007–2020 |
| Westborough, Massachusetts, US | 3 | 1999–2003 |
| Brighton, Massachusetts, US | 2 | 1998–2000 |